Posters

The iStent implantation in combination with SLT as an effective method of lowering intraocular pressure in patients with glaucoma

Poster Details

First Author: M.Hajduga POLAND

Co Author(s):    I. Filipecka   M. Hajduga   K. Posłuszny-Rutkowska   Ł. Drzyzga   E. Mrukwa-Kominek        

Abstract Details

Purpose:

The efficacy of treatment of cataract phacoemulsification with implantation of an artificial intraocular lens and micro-stent iStent performed in patients without and after selective laser trabeculoplasty (SLT) were compared. The objective of the study was to analyze the test results of patients who underwent cataract phacoemulsification with implantation of an artificial intraocular lens and micro-stent iStent - group 1 without previous SLT procedure and group 2 after SLT operation was analyzed.

Setting:

Treatments were performed at the Okulus Plus Center of Ophthalmology and Optometry in Bielsko-Biała and at the University Clinical Center Professor K. Gibinski of the Medical University of Silesia in Katowice, Poland.

Methods:

Before the surgery, eye diagnostics were performed and prophylaxis was recommended to reduce the risk of infection and post-operative complications.  The study group included 33 operated patients aged 59-81 with diagnosed primary open angle glaucoma and secondary glaucoma. 43 eyes were operated - 25 in group 1 and 18 in group 2. The intraocular pressure (IOP) and the amount of anti-glaucoma medications used before surgery and at 3., 6. and 9. months after surgery were compared.

Results:

After 3 months of observation in group 1 the intraocular pressure (IOP) was reduced by 3.9 mmHg compared to IOP before the procedure and in the second group by 3.7 mmHg. After 6 months of observation IOP was reduced by 3.3 mmHg in first group and 4.4 mmHg in second group. Both after 3 and after 6 months of observation the required number of IOP reducing substances was reduced by 1.7 in the same period in group 1 and 2.2 in group 2. After 9 months of observation the results were similar to those after 6 months in both groups.

Conclusions:

In the observation of a nine-month cataract phacoemulsification procedure with implantation of an artificial intraocular lens and micro-stent iStent surgery more effectively reduces IOP in patients with previously performed SLT and significantly reduces the amount of substances used to reduce IOP in eye drops.

Financial Disclosure:

... gains financially from competing product or procedure, ... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... receives non-monetary benefits from a company producing, developing or supplying the product or procedure presented, ... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, ... is employed by a competing company, ... has significant investment interest in a company producing, developing or supplying product or procedure presented